|
Federal Register
Notices
> Notice of Registration - 2009
>
Johnson Matthey Inc
FR Doc E9-13355[Federal Register: June 9, 2009 (Volume 74, Number 109)]
[Notices] [Page 27350] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09jn09-104]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated January 9, 2009, and published in the Federal Register on
January 21, 2009, (74 FR 3642), Johnson Matthey Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West Deptford, New Jersey 08066-1742, made
application by renewal to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the basic classes of controlled substances
listed in schedules I and II:
|
Drug
|
Schedule
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Dihydromorphine (9145)
|
I
|
|
Difenoxin (9168)
|
I
|
|
Propiram (9649)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Lisdexamfetamine (1205)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Nabilone (7379)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Dihydrocodeine (9120)
|
II
|
|
Oxycodone (9143)
|
II
|
|
Hydromorphone (9150)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Meperidine (9230)
|
II
|
|
Methadone (9250)
|
II
|
|
Methadone intermediate (9254)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Noroxymorphone (9668)
|
II
|
|
Alfentanil (9737)
|
II
|
|
Remifentanil (9739)
|
II
|
|
Sufentanil (9740)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture the listed controlled substances in bulk for
sale to its customers.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Johnson Matthey Inc.
to manufacture the listed basic classes of controlled substances is consistent
with the public interest at this time. DEA has investigated Johnson Matthey Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance with State
and local laws, and a review of the company's background and history. Therefore,
pursuant to 21
U.S.C. 823, and in accordance with 21 CFR
1301.33, the above
named company is granted registration as a bulk manufacturer of the basic
classes of controlled substances listed.
Dated: June 3, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-13355 Filed 6-8-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|